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Abstract S5.4 
Deciphering the role of HD52, a mitochondrial nucleotidase essential for pyrimidine homeostasis 
in Trypanosoma brucei 
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Objectives: We aimed to elucidate the role of TbHD52, a nucleotidase that belongs to the SAMHD1 family, in dTTP 
biosynthesis and pyrimidine homeostasis in Trypanosoma brucei.  
Methods: Intracellular localization of TbHD52 was determined by immunofluorescence studies. TbHD52 knock-out 
cell lines were generated upon thymidine supplementation to further establish the impact of TbHD52 on cell viability, 
cell cycle progression and pyrimidine homeostasis. Several cell lines overexpressing enzymes involved in pyrimidine 
metabolism, such as hDCTD or TbCDA, in a TbHD52-dKO background were also generated for a more 
comprehensive study. Additionally, metabolomics studies were performed in order to identify global disturbances, 
specifically in dNTP homeostasis, in the absence of TbHD52. 
Results: TbHD52 is an exclusive mitochondrial nucleotidase essential for Trypanosoma brucei viability, as knock-out 
cells are pyrimidine auxotrophs. Additionally, our findings show that the lack of HD52 can be counteracted by the 
expression of enzymes involved in dUMP formation. In the absence of exogenous thymidine or deoxyuridine 
supplementation, TbHD52-dKO cells show strong defects in cell cycle progression and nuclei and kinetoplast 
segregation. Furthermore, the metabolomics profile was severely perturbed, affecting profoundly cytosine- and 
thymidine-derived metabolites.  
Conclusions: TbHD52 is an essential enzyme in Trypanosoma brucei and our results suggest that it plays a key role 
providing mitochondrial deoxycytidine and thymidine for dTTP biosynthesis via TK salvage. Thus, our findings firmly 
support that TbHD52 is a valuable drug target against African trypanosomiasis.   
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